NASDAQ · ONC
BeOne Medicines Ltd.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for ONC: Nov 05, 2026
BeOne Medicines Ltd. American Depositary Shares is expected to report earnings on 11/05/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $2.34. The reported EPS for the same quarter last year was $1.09.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $2.34 | $2.56 | $2.12 | 2 |
| Dec 2026 | $2.10 | $2.15 | $2.04 | 2 |
| Mar 2027 | $2.93 | $2.98 | $2.88 | 2 |
| Jun 2027 | $3.27 | $3.33 | $3.21 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · The Motley Fool · MarketBeat · BNK Invest- Zacks · Oct 15, 11:00 AM EDTAll You Need to Know About BeOne Medicines Ltd. – Sponsored ADR (ONC) Rating Upgrade to Strong BuyBeOne Medicines Ltd. – Sponsored ADR (ONC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
- Zacks · Oct 15, 4:02 AM EDTNew Strong Buy Stocks for October 15thKMX, ACIC, ONC, ODD and WES have been added to the Zacks Rank #1 (Strong Buy) List on October 15, 2026.
- Zacks · Sep 1, 12:35 PM EDTTrump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized DrugmakersTrump's MFN push expands to nine mid-sized drugmakers, bringing 26 companies under agreements covering 89% of the branded drug market.
- Zacks · Aug 27, 4:54 PM EDTGenerative "AI" Macro Data Shows U.S. ImpactsThere are solid gains to knowledge workers. But smaller ones outside it.
- Zacks · Aug 27, 12:00 PM EDTBeOne Medicines Ltd. – Sponsored ADR (ONC) is a Great Momentum Stock: Should You Buy?Does BeOne Medicines Ltd. – Sponsored ADR (ONC) have what it takes to be a top stock pick for momentum investors? Let's find out.
- Zacks · Aug 25, 9:55 AM EDTBeOne Medicines Ltd. – Sponsored ADR (ONC) Now Trades Above Golden Cross: Time to Buy?Is it a good or bad thing when a stock experiences a golden cross technical event?
- The Motley Fool · Aug 12, 11:28 AM EDTBeOne Medicines (ONC) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 5, 2:04 PM EDTBeOne Medicines Q2 Earnings Call Highlights4 Stocks With Huge Cash Holdings at Silicon Valley BankBeOne Medicines (NASDAQ:ONC) reported second-quarter revenue of $1.7 billion, up 30% from a year earlier, and GAAP earnings per ADS of $2.05, up 144%, as sales of its BTK inhibitor BRUKINSA continued to expand across approved
- Zacks · Aug 5, 9:30 AM EDTBeOne Medicines Ltd. – Sponsored ADR (ONC) Q2 Earnings: How Key Metrics Compare to Wall Street EstimatesWhile the top- and bottom-line numbers for BeOne Medicines Ltd. – Sponsored ADR (ONC) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- Zacks · Aug 4, 9:15 AM EDTCountdown to BeOne Medicines Ltd. – Sponsored ADR (ONC) Q2 Earnings: A Look at Estimates Beyond Revenue and EPSLooking beyond Wall Street's top-and-bottom-line estimate forecasts for BeOne Medicines Ltd. – Sponsored ADR (ONC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2026.
- BNK Invest · Jul 29, 10:51 AM EDTNoteworthy ETF Outflows: FBT, ONC, HALO, NEOLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the First Trust NYSE Arca Biotechnology Index Fund (Symbol: FBT) where we have detected an approximate $427.2 million dollar outflow — that's a 13.0% d
- RTTNews · Jul 23, 9:33 AM EDTBeOne Medicines Expands U.S. Manufacturing With $1 Billion Investment(RTTNews) – BeOne Medicines Ltd. (ONC) announced a $300 million expansion of its flagship manufacturing and R&D center at the Princeton West Innovation Campus in Hopewell, New Jersey, bringing its total U.S. manufacturing investment to more than $1 billion.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for BeOne Medicines Ltd. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.